Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Methodology and Healthcare Policy
Vol. 1, Issue 3, 2014
February 26, 2016 EDT
The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
Zeynal Karaca
,
Steven N. Wiggins
,
meps
prescription drugs
healthcare expenditures
drug classes
Copyright Logo
ccby-4.0
Photo by
Haley Lawrence
on
Unsplash
JHEOR
1.
Karaca Z, Wiggins SN. The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures.
JHEOR
. 2016;1(3):276-295.
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats